Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Accelerating the Translation of Parkinson's Disease Therapies, 2022
    Esya PD360: A Multi-parametric Platform for Establishing a Novel Lysosome-based Biomarker and Identifying Therapeutic Interventions for Parkinson’s Disease

    Study Rationale: Lysosomes are sub-cellular compartments responsible for clearing proteins that are prone to aggregation, a process called autophagy. Dysfunctional lysosomes with increased acidity and...

  • Research Grant, 2022
    Perspective and Consensus on Prevention Planning for Parkinson’s Disease

    Study Rationale: In October 2022, a conference on “Planning for Prevention of Parkinson's: A trial design forum” gathered a broad range of stakeholders interested in preventing Parkinson’s disease (PD...

  • Research Grant, 2022
    Registry for the Advancement of DBS in Parkinson’s Disease (RAD-PD)

    Study Rationale: RAD-PD is a quality improvement patient registry project that will address clinical questions about deep brain stimulation (DBS) therapy that cannot be practically answered via the...

  • Therapeutic Pipeline Program, 2022
    Evaluating the Efficacy of a mGluR5 Modulator in Preclinical Models of Parkinson’s Disease

    Study Rationale: Parkinson’s disease (PD) is one of many neurodegenerative diseases that are characterized by the buildup of misfolded protein aggregates in the brain. Preclinical data suggest that...

  • Research Grant, 2022
    Interaction of Mitochondrial Genes and Lifestyle Factors on Age at Onset in Parkinson’s Disease

    Study Rationale: Cellular structures called mitochondria are functionally impaired in Parkinson’s disease (PD). How environmental toxins or lifestyle factors influence mitochondrial function and...

  • Outcome Measures, 2022
    Improving the generalizability and robustness of MRI-derived biomarkers of Parkinson's Disease through analytical and data variability evaluations

    Study Rationale: Medical imaging is a promising technique to help with the early diagnosis, understanding, and treatment of Parkinson's disease. Indeed, using advanced image acquisition techniques and...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.